Literature DB >> 17019439

Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers.

Slawa Szostek1, Malgorzata Klimek, Barbara Zawilinska, Janusz Rys, Jolanta Kope, Ewa Daszkiewic.   

Abstract

The purpose of this study was to compare hybrid capture assay with PCRs using different primers for the L1, E6-E7 regions for the detection of human papillomavirus (HPV) genome. One hundred twenty-five cervical smears with normal (n=42) and abnormal (n=83) cytology were investigated. Those at high-risk for HPV were studied by hybridization antibody capture assay and PCR with the pU-1M/pU-2R primers. Target DNA from the HPV L1 region was amplified by SPF10 primer set and home-PCR with MY09/MY11 primers. The presence of HPV DNA in cervical smears was detected by SPF10 (in 72% of cases), MY09/MY11 (58%), hybrid capture (55%) and pU-1M/pU-2R (39%). Results obtained with the SPF10 and MY09/MY11 consensus primer sets as well as hybrid capture and pU-1M/pU-2R specific for high-risk types differed significantly (chi2, P<0.0005). The correlation between assays with the use of SPF10 and MY09/MY11 was 86% and between hybrid capture and the pU-1M/pU2R technique--78%. In 49% of samples HPV DNA was detected by the four methods, whereas in 12% only by the SPF10 primers. The most sensitive technique was found to be PCR with the use of SPF10 primers, while the most specific--the MY09/11 PCR method. It seems that home-PCR with MY09/MY11 primers could be applied in screening tests.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17019439

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  6 in total

Review 1.  Association between viral infection other than human papillomavirus and risk of esophageal carcinoma: a comprehensive meta-analysis of epidemiological studies.

Authors:  Hui Geng; Yaqi Xing; Jingbing Zhang; Kexin Cao; Meijie Ye; Geng Wang; Caixia Liu
Journal:  Arch Virol       Date:  2021-10-12       Impact factor: 2.574

2.  Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009.

Authors:  Keivan Zandi; Seyed Sajjad Eghbali; Rasool Hamkar; Shahnaz Ahmadi; Elissa Ramedani; Iman Deilami; Heidar Aziz Nejad; Fatemeh Farshadpour; Zahra Rastian
Journal:  Virol J       Date:  2010-03-22       Impact factor: 4.099

3.  Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.

Authors:  Marina Munoz; Milena Camargo; Sara C Soto-De Leon; Ricardo Sanchez; Diana Parra; Andrea C Pineda; Otto Sussmann; Antonio Perez-Prados; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

4.  Prevalence of human papillomavirus genotypes in cervical cancer in Maiduguri, Nigeria.

Authors:  Abba Kabir; Mwajim Bukar; Haruna Asura Nggada; Harun Bakari Rann; Abubakar Gidado; Alhaji Bukar Musa
Journal:  Pan Afr Med J       Date:  2019-08-05

5.  Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination.

Authors:  Jeanne M Pimenta; Claudia Galindo; David Jenkins; Sylvia M Taylor
Journal:  BMC Cancer       Date:  2013-11-21       Impact factor: 4.430

6.  Molecular detection and immunopathological examination of Deltapapillomavirus 4 in skin and udder of Egyptian cattle.

Authors:  Emad Beshir Ata; Mohamed Abd El-Fatah Mahmoud; A A Madboli
Journal:  Vet World       Date:  2018-07-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.